Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Carcinoma, Small Cell 1

Interventions

Pemetrexed 3Gemcitabine 3Topotecan 2Carboplatin 2vosaroxin 1vinflunine 1taxane 1pembrolizumab 1lurtotecan 1liposomal doxorubicin 1enzalutamide 1bemiparin 1apalutamide 1abiraterone 1Vinorelbine 1Temozolomide 1RRx-001 1Paclitaxel 1Nivolumab 1Irinotecan 1Ipilimumab 1Etoposide 1Docetaxel 1Cisplatin 1BI 2536 1Arsenic Trioxide 1ARQ 197 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Small Cell × bemiparin × Clear all
NCT00324558 2012-06-08

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

Clinica Universidad de Navarra, Universidad de Navarra

Phase 2 Terminated
39 enrolled
Thoracic

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡